Cargando…
Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice
INTRODUCTION: Breast cancer is one of the most important health problems in the world. In recent years, this cancer has achieved a reduction in mortality, which is attributed to the introduction of mass screening and greater efficacy of post-operative treatment. Many patients with breast cancer have...
Autores principales: | Adamowicz, Krzysztof, Baczkowska-Waliszewska, Zuzanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216605/ https://www.ncbi.nlm.nih.gov/pubmed/32398097 http://dx.doi.org/10.1186/s12955-020-01389-x |
Ejemplares similares
-
Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients – in view of the recent evidence
por: Serkies, Krystyna, et al.
Publicado: (2021) -
Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
por: Basseville, Agnes, et al.
Publicado: (2022) -
Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)
por: Marvaso, Giulia, et al.
Publicado: (2019) -
Adjuvant Hormonotherapy and Cardiovascular Risk in Post-Menopausal Women with Breast Cancer: A Large Population-Based Cohort Study
por: Franchi, Matteo, et al.
Publicado: (2021) -
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial
por: Bourgier, Céline, et al.
Publicado: (2018)